These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 231702)

  • 1. Potentiation of the algogenic action of bradykinin by an inhibitor of angiotensin I converting enzyme, captopril (SQ 14,225).
    Nakano T; Taira N
    Jpn J Pharmacol; 1979 Aug; 29(4):563-71. PubMed ID: 231702
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of [3H]benzoyl-phenylalanyl-alanyl-proline by pulmonary angiotensin converting enzyme in vivo: effects of bradykinin, SQ 14225 or acute hypoxia.
    Catravas JD; Gillis CN
    J Pharmacol Exp Ther; 1981 May; 217(2):263-70. PubMed ID: 6262480
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of SQ 20881 and captopril on mesenteric, renal, and iliac vasculatures.
    Fiksen-Olsen MJ; Britton SL; Houck PC; Romero JC
    Am J Physiol; 1983 Mar; 244(3):H313-9. PubMed ID: 6187226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal involvement in captopril-induced potentiation of morphine analgesia.
    Das S; Chatterjee TK; Ghosh JJ
    Eur J Pharmacol; 1982 Nov; 85(2):217-20. PubMed ID: 6295781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
    Félétou M; Germain M; Teisseire B
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H839-45. PubMed ID: 1558194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
    Persson K; Andersson RG
    Eur J Pharmacol; 1999 Nov; 385(1):21-7. PubMed ID: 10594341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment.
    Mullane KM; Moncada S
    Eur J Pharmacol; 1980 Sep; 66(4):355-65. PubMed ID: 6998710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig.
    Greenberg R; Osman GH; O'Keefe EH; Antonaccio MJ
    Eur J Pharmacol; 1979 Aug; 57(4):287-94. PubMed ID: 385332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of bradykinin-induced decrease of blood pressure in dogs by SO 14,551, the disulfide metabolite of captopril.
    O'Hara N; Ono H; Hashimoto K
    Jpn J Pharmacol; 1982 Oct; 32(5):934-7. PubMed ID: 6757503
    [No Abstract]   [Full Text] [Related]  

  • 10. Converting enzyme inhibition in the rat by captopril is accompanied by potentiation of carrageenin-induced inflammation.
    Boura AL; Svolmanis AP
    Br J Pharmacol; 1984 May; 82(1):3-8. PubMed ID: 6329390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B; de Vries R; Saxena PR; Danser AH
    Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intracoronary captopril on coronary blood flow and regional myocardial function in dogs.
    Noguchi K; Kato T; Ito H; Aniya Y; Sakanashi M
    Eur J Pharmacol; 1985 Mar; 110(1):11-9. PubMed ID: 3891380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SQ 14,225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries.
    Okuno T; Kondo K; Konishi K; Saruta T; Kato E
    Life Sci; 1979 Oct; 25(15):1343-9. PubMed ID: 390286
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of bradykinin potentiation in the antihypertensive effect of captopril in conscious rabbits with two-kidney, one-clip hypertension.
    Takata M; Sugimoto T; Matsumoto M; Iida H; Mizumura Y
    J Cardiovasc Pharmacol; 1981; 3(6):1260-8. PubMed ID: 6173526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced contractility of the rat stomach during suppression of angiotensin converting enzyme by captopril in vitro.
    Rani R; Rao KS
    Br J Pharmacol; 1991 Apr; 102(4):827-30. PubMed ID: 1713107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the protective effect of angiotensin-converting enzyme inhibition in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):54-7. PubMed ID: 228313
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
    Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of vascular permeability changes in rats by captopril.
    Fantone JC; Schrier D; Weingarten B
    J Clin Invest; 1982 Jun; 69(6):1207-11. PubMed ID: 6282931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.